60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPW – Get Free Report) saw a significant decline in short interest in the month of September. As of September 30th, there was short interest totaling 1,102 shares, a decline of 42.9% from the September 15th total of 1,931 shares. Based on an average daily volume of 1,592 shares, the short-interest ratio is currently 0.7 days.
60 Degrees Pharmaceuticals Stock Up 1.6%
Shares of SXTPW traded up $0.00 during mid-day trading on Thursday, reaching $0.03. The company had a trading volume of 874 shares, compared to its average volume of 9,402. 60 Degrees Pharmaceuticals has a 52-week low of $0.02 and a 52-week high of $0.15. The stock has a 50 day moving average of $0.03 and a two-hundred day moving average of $0.04.
60 Degrees Pharmaceuticals Company Profile
60 Degrees Pharmaceuticals, Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for infectious diseases. The company’s work has centered primarily on malaria prevention and treatment, with an emphasis on products that address unmet needs in travelers, military personnel and other populations at risk of infection.
The company’s lead product is Arakoda (tafenoquine), an oral antimalarial approved by the U.S. Food and Drug Administration for the prevention of malaria in adults.
Recommended Stories
- Five stocks we like better than 60 Degrees Pharmaceuticals
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
- Fastenal Flashes Bullish Signal as Uptrend Holds Despite Margin Pressure
Receive News & Ratings for 60 Degrees Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
